ðïž ç¬ç« è «çãã¥ãŒã¹ â 2026.06.21
ç¬ç«ã®è «çã»ããé¢é£ãã¥ãŒã¹ïŒè«æ èš7ä»¶
ðïž è «çã»ããé¢é£ãã¥ãŒã¹ â 2026.06.21
æ¬æ¥ 7ä»¶
1. ð¥ å»çã»çŸç ã»äºé²
ç¬ç«ã®ããã蚺çã¬ã€ãã©ã€ã³ããå·æ°ââAAHAã2026幎çãªã³ã³ããžãŒã¬ã€ãã©ã€ã³ãå ¬é
ð 2026
ç±³åœåç©ç é¢åäŒïŒAAHAïŒãã2026幎ç ç¬ãšç«ã®ãã蚺çã¬ã€ãã©ã€ã³ããå ¬éããã蚺æããæ²»çãç·©åã±ã¢ãŸã§ãç¶²çŸ ãããç£å»è «çåŠã®ææ°ãããã¯ïŒWhat's NewïŒãã®ç« ã§ã¯ãè¿å¹Žå®çšåãé²ãæ°ããæ²»çéžæè¢ãæŽçãããŠãããå ·äœçã«ã¯ãé転移æ§ã®ç¬ã®è¥æºçްèè «ã«å¯Ÿããå±ææ³šå°è¬ãã®ã©ããŒã«ãã°ã¬ãŒãïŒStelfontaïŒããç¬ã®ãªã³ãè «ã«æ£åŒæ¿èªãããã©ãã«ãã©ãµãžã³ïŒTanoveaïŒããããŠUSDAã©ã€ã»ã³ã¹ãåããã¡ã©ããŒãã¯ã¯ãã³ïŒOnceptïŒãæPD-1æäœgilvetmabãªã©ãèšåãããŠããã
ã¬ã€ãã©ã€ã³ã¯äžè¬ã®åç©ç é¢ã®ç£å»åž«ããå°éå»ã«ç޹ä»ãã¹ãã¿ã€ãã³ã°ãææ°ã®æšæºæ²»çã倿ããããã®å®åçãªæåŒããšãªããããã¯ç¬ç«ã®æ»å ã®äžäœãå ãã飌ãäž»ã«ãšã£ãŠããã©ããŸã§æ²»çãããããQOLãã©ãå®ãããã¯åå®ãªåé¡ã ãæ°ããè¬ãæ€æ»ã次ã ç»å ŽããããŸãä¿¡é Œã§ããæ å ±ã«åºã¥ããŠäž»æ²»å»ãšçžè«ã§ããåå°ãæŽãæçŸ©ã¯å€§ãããæç¬ã»æç«ã«ããããåå äžæã®äœèª¿äžè¯ãããã°ãæ©ãã«çްè蚺ãªã©ã®æ€æ»ãåããŠã»ããã
ð https://www.aaha.org/resources/2026-aaha-oncology-guidelines-for-dogs-and-cats/
ð·ïž å»çã»çŸç ã»äºé²
2. 𧬠ç ç©¶ã»ç§åŠ
ç¬ã®ãªã³ãè «ã«ãåã®é£²ã¿è¬ããæ£åŒæ¿èªââãã«ãžãã¯ãµãŒïŒLaverdiaïŒã160é ã®è©ŠéšãçµãŠFDAæ¬æ¿èªïŒ2026幎1æïŒ
ð 2026.01
ç¬ã®ãªã³ãè «æ²»çè¬ãã«ãžãã¯ãµãŒïŒè£œååLaverdia-CA1ïŒãã160é èŠæš¡ã®æ±ºå®çãã£ãŒã«ã詊éšãçµãŠã2026幎1æã«FDAããæ¬æ¿èªïŒãã«æ¿èªïŒãåãããããã¯ç¬ã®ãªã³ãè «ã«å¯Ÿãããåã®çµå£ïŒé£²ã¿è¬ïŒæ²»çè¬ãã§ããããŸã§ç¹æ»Žã»æ³šå°ãäžå¿ã ã£ãæ²»çã«èªå® ã§é£²ãŸããããéžæè¢ãå ãããäœçšæ©åºã¯ãŠããŒã¯ã§ããã现èå ã«éã蟌ããããŠãããããæå¶ã¿ã³ãã¯è³ªãã®æ žå€ãžã®æåºãé»å®³ããæ¬æ¥ã®åããåãæ»ãããããšã§å¢æ®ãšè»¢ç§»ãæãããæ©æã®ç¬¬IIçžè©Šéšã§ã¯åå€ã§ã®å¥å¹çã¯37%ã ã£ãããTçŽ°èæ§ãªã³ãè «ã§ã¯71%ãšé«ãåå¿ã瀺ããã
泚å°ã®ããã«é »ç¹ã«éé¢ããè² æ ãæžãããšã¯ãç¬ã«ã飌ãäž»ã«ã倧ããªã¡ãªããã ãæ³šå°å€ã®ã©ãã«ãã©ãµãžã³ïŒTanoveaïŒãšåãããç¬ã®ãªã³ãè «æ²»çã¯ã泚å°ãšçµå£ããäœçšæ©åºã®ç°ãªãè¬ããç æ ã飌ãäž»ã®åžæã«å¿ããŠçµã¿åãããã人å»çã«è¿ããã现ããªæ®µéãžé²ã¿ã€ã€ãããäžæ¹ã§çµå£æããå€ã¯å®¶åºã§ã®åãæ±ãã«æ³šæãå¿ èŠã§ãæè¢ã®ççšãææ³ç©ã®åŠçãªã©å®å šç®¡çãæ±ãããããæäžã®å¯åŠãæ¹æ³ã¯è «çç§ã®ç£å»åž«ãšããçžè«ãã
ð https://www.dvm360.com/view/fda-grants-full-approval-to-laverdia-for-canine-lymphoma
3. 𧬠ç ç©¶ã»ç§åŠ
ã2ã€ã®å ç«ãã¬ãŒãããåæã«å€ãââç¬ã®åºåœ¢ããã«äºéãã§ãã¯ãã€ã³ãçæ³ãåã®1é ã«æäžéå§ïŒCheckmate K9ïŒ
ð 2026
ç±³ãŠã£ã¹ã³ã³ã·ã³å€§ã§ãç¬ã®ããŸããŸãªåºåœ¢ããã察象ã«ããäºéå ç«ãã§ãã¯ãã€ã³ãçæ³ã®ãã€ãããèšåºè©ŠéšãCheckmate K9ããå§ãŸããæåã®1é ãžã®æäžãè¡ããããããããã€ãªããã¯äŒæ¥VetigenicsãéçºããVGS 001ïŒæCTLA-4ã¢ãã¯ããŒãã«æäœïŒãšVGS 002ïŒæPD-1ã¢ãã¯ããŒãã«æäœïŒã䜵çšãããã®ã§ãå®å šæ§ãšåæã®æå¹æ§ãè©äŸ¡ããã人ã®ããå ç«çæ³ã§ã¯ãCTLA-4ããšãPD-1ããšãã2ã€ã®å ç«ã®ãã¬ãŒããåæã«å€ã䜵çšçæ³ãé«ã广ãäžããŠãããããããç¬å°çšã®æäœã§åçŸããããšãã詊ã¿ã ã
åå€ã®æPD-1æäœïŒgilvetmabãªã©ïŒã¯ãã§ã«äžéšã§äœ¿ããå§ããŠããããäºå€äœµçšã¯ãã匷åã«ãããžã®å ç«æ»æãåŒãåºããå¯èœæ§ãããäžæ¹ãå ç«é¢é£ã®å¯äœçšã«ã泚æãå¿ èŠãšãªããç¬ã§åŸãããç¥èŠã¯ãèªç¶çºçãããä»ããŠäººã®ããæ²»çã«ããã£ãŒãããã¯ããããæ¯èŒè «çåŠïŒOne HealthïŒãã®çºæ³ã«åºã¥ãããŸã åææ®µéã®è©Šéšã ããæ¢åæ²»çãå¹ãã«ããåºåœ¢ããã®ç¬ã«æ°ããªåžæãããããããä»åŸã®ããŒã¿ã泚ç®ãããã
ð https://www.dvm360.com/view/first-dog-receives-combination-immunotherapy-in-new-cancer-trial
4. ð¥ å»çã»çŸç ã»äºé²
æ²»çãé£ãããç¬ã®è³è «çïŒã°ãªãªãŒãïŒãã«æ°ææ³ãç¶ã ââè¬ãè «çãžçŽæ¥æ³šå ¥ãèå ã§å ãããŠåé€
ð 2026
ã°ãªãªãŒãïŒç¥çµè è «ïŒã¯ç¬ã®è³è «çã§æãå€ãã¿ã€ãã®äžã€ã ããæ²»çãé£ããäºåŸãå³ãããããã«å¯Ÿããç±³åœã®è€æ°ã®ç£å»å€§åŠãæ°ããã¢ãããŒãã®èšåºè©Šéšãé²ããŠãããããŒãžãã¢å·¥ç§å€§åŠãšãŠã§ã€ã¯ãã©ã¬ã¹ã倧ã®è³è «çç ç©¶ã»ã³ã¿ãŒã¯ãè «çå ã«å°çšã«ããŒãã«ãç眮ããŠååæšçè¬ïŒçŽ°èæ¯çŽ ïŒãæ°æéãããŠãã£ããæ³šå ¥ããã察æµåŒ·åééïŒCEDïŒãã詊éšäžã ãäžæ¹UC Davisã¯ãç¹æ®ãªèå æè¡ã§è «çãå ãããæ£åžžãªè³çµç¹ãšã®å¢çãèŠæ¥µããªããåé€ãããèå ã¬ã€ãæè¡ãã®è©Šéšã«æ£è ãç»é²ããŠãããããã«ã·ã³ã¯ãããã³ãçšããããã€ã¯ãããŒã æŸå°ç·æ²»çïŒMRTïŒãããåŸæ¥ã®æŸå°ç·ããé«ãè «çå¶åŸ¡ãæåŸ ãããç¬ã§å®å šæ§ãæ€èšŒãããŠããã
è³ã¯æè¡ãè¬ã®å°éãé£ããèåšã§ããããŸã§ç¬ã®ã°ãªãªãŒãã¯éžæè¢ãéãããŠãããè «çã«è¬ãçŽæ¥å±ãããå¢çãå¯èŠåããããã粟å¯ã«æŸå°ç·ãåœãŠãââãããããæ£åžžãªè³ãå®ããªããè «çã ããå©ããããšãç®æãæè¡ã ãããããçºäœããµãã€ããè¡åã®å€åãªã©ç¥çµçç¶ãç¶ãå Žåã¯è³è «çã®å¯èœæ§ãããã®ã§ãMRIã«ãã粟æ»ãå«ããŠç¥çµç§ã»è «çç§ã®ããæœèšã«çžè«ãã
ð·ïž å»çã»çŸç ã»äºé²
5. 𧬠ç ç©¶ã»ç§åŠ
ç¬ã®ãå£è ã¡ã©ããŒããã«æ°ããéºäŒåã¯ã¯ãã³ã®è©Šéšââã¢ããé䌎ãŠã€ã«ã¹ïŒAAVïŒãäœ¿ãæ°äžä»£ã®æ²»ç
ð 2026
å£è ïŒå£ã®äžïŒã®æªæ§é»è²è «ïŒã¡ã©ããŒãïŒã¯ç¬ã§æãå€ãå£è ããã®äžã€ã§ãæè¡ã ãã§ã¯é²è¡ãæ©ããã¹ããŒãžIIãIIIã§ã¯çåæéã5ã6ã¶æã«ãšã©ãŸãããšãããããããœã¿å€§ã®èšåºè©ŠéšããŒã ã¯ãã¢ããé䌎ãŠã€ã«ã¹ïŒAAVïŒããã¯ã¿ãŒã«çšããæ°ããã¡ã©ããŒãã¯ã¯ãã³ã®å®å šæ§ãšæå¹æ§ãè©äŸ¡ãã詊éšãé²ããŠããïŒ2026幎5ææç¹ã§ã¯ã¯ã¯ãã³ã®è¿œå äŸçµŠãåŸ ã£ãŠäžæäŒæ¢äžã§ãå€ã«åéäºå®ïŒãåŸæ¥ã®Onceptã¯ã¯ãã³ïŒããã·ããŒãŒãæšçãšããDNAã¯ã¯ãã³ïŒã§ã¯ãæè¡åŸã«ã¯ã¯ãã³ãåãã58é ã§çåæéã®ååäœå€ã464æ¥ãšãæªæ¥çš®ã®156æ¥ã倧ããäžåã£ããšã®å ±åãããäžæ¹ãæå¹æ§ã«ã€ããŠã¯èŠè§£ãåãããŠããçµç·¯ãããã
AAVãã¯ã¿ãŒã¯éºäŒåãå¹çããäœå ã«å±ããããæ°äžä»£ã®æè¡ã§ããã匷ãæç¶çãªæè «çå ç«ãåŒãåºããããçŠç¹ã ãå£è ã¡ã©ããŒãã¯æ©æçºèŠãé£ãããå£èãåºè¡ãé£ã¹ã¥ããã§æ°ã¥ãããããšãå€ããæ¥é ããæç¬ã®å£ã®äžã芳å¯ããé»ã£ãœãããããæ²»ããªã朰çãããã°æ©ãã«å蚺ããæ°ããã¯ã¯ãã³ãå®çšåãããã°ãæè¡ã»æŸå°ç·ã«ç¶ã第3ã®æ±ãšããŠæ²»çã®å¹ ãåºããå¯èœæ§ãããã
6. ð¥ å»çã»çŸç ã»äºé²
ãåããã«æ²»ããè¥æºçްèè «ã®æ³šå°è¬Stelfontaãéãå¯äœçšã®çäŸå ±åââ䟿å©ãã®è£ã®ãªã¹ã¯ã«æ³šæïŒ2026幎ïŒ
ð 2026
ç¬ã®è¥æºçްèè «ïŒMCTïŒã«å¯Ÿããæè¡ããè «çã«çŽæ¥æ³šå°ããŠå£æ»ãããè¬ãã®ã©ããŒã«ãã°ã¬ãŒãïŒStelfontaïŒã¯ãã©ã³ãã å詊éšã§1åæäžã«ãã28æ¥ç®ã«75%ãå®å šå¥å¹ãã84æ¥æç¹ã§93%ãåçºããªãã£ããšå ±åãããææãªå±æçæ³ã ãããã2026幎ã«Frontiers in Veterinary Scienceã«çºè¡šãããçäŸå ±åã¯ããã®éãå¯äœçšãèšé²ãããåŸè¢ïŒè¶³éŠïŒã®ç®äžè¥æºçްèè «ã«å¯Ÿã1å2mLãè «çå æ³šå°ãã10æ³ã®éç¬ãã24æé以å ã«ååã»äžç¢ã»åŸªç°è¡æ¶²éæžå°æ§ã·ã§ãã¯ã»èµçãçºçããå ¥é¢ãšéäžçãªæ¯æçæ³ãèŠãããšããã
ãã®è¬ã¯è «çãåºè¡æ§å£æ»ã§ç Žå£ãã壿»çµç¹ãè±èœããåŸã®æ¬ æãäºæ¬¡æ²»çã§æ²»ãä»çµã¿ã§ãäžè¬ã«ã¯å®å šæ§ãé«ããšããããããã§ãä»åã®ããã«å šèº«æ§ã®é節ãªå䜵çãèµ·ããããããšã瀺ããç¹ã§ãçäŸéžæãšé£Œãäž»ãžã®ååãªèª¬æïŒã€ã³ãã©ãŒã ãã»ã³ã³ã»ã³ãïŒã®éèŠæ§ãæ¹ããŠæµ®ã圫ãã«ãªã£ãããåããã«æ²»ãããæè»œãã¯å€§ããªé åã ããè «çã®å€§ããã»éšäœã»ã°ã¬ãŒãã«ãã£ãŠé©åŠã¯å€ãããè «çç§ã®ç£å»åž«ãšãæè¡ãå«ãä»ã®éžæè¢ãšæ¯èŒããããã§å€æããŠã»ããã
ð https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2026.1757258/full
ð·ïž å»çã»çŸç ã»äºé²
7. 𧬠ç ç©¶ã»ç§åŠ
ç«ã®ãä¹³è ºããããã¿ã³ãã¯è³ªã§èŠåããââæªæ§åºŠããšã®ç¹åŸŽãããããªãã¯ã¹ã§è§£æãæ©æçºèŠã®æãããã«ïŒ2026幎ïŒ
ð 2026
ä¹³è ºããïŒä¹³è ºçïŒã¯ã¡ã¹ç«ã®æ»äº¡åå ãšããŠéèŠãªãæªæ§åºŠã®é«ãè «çã§ãå€ç§çã«åé€ããŠãåçºã転移ãå€ãã2026幎ã«Veterinary and Comparative Oncologyèªã«çºè¡šãããç ç©¶ã¯ãç«ã®ä¹³è ºãã31äŸãšæ£åžžãªä¹³è ºçµç¹6äŸã«ã€ããŠãæ¶²äœã¯ãããã°ã©ãã£ãŒã»ã¿ã³ãã 質éåæïŒLC-MS/MSïŒã§ã¿ã³ãã¯è³ªã®çºçŸãããã¡ã€ã«ãæ¯èŒããããã®çµæãçµç¹åŠçãªã°ã¬ãŒãïŒæªæ§åºŠïŒããšã«ã¿ã³ãã¯è³ªã®ãã¿ãŒã³ãç°ãªãããšãçªãæ¢ããæ©æçºèŠãæ²»çæ³éžæã®æããããšãªãåè£ãã€ãªããŒã«ãŒãåå®ããã
éºäŒåïŒã²ãã ïŒã«å ããŠã¿ã³ãã¯è³ªïŒããããªãŒã ïŒã®ã¬ãã«ã§è «çãèªã¿è§£ãããšã§ãããã®ç«ã®è «çã¯ã©ããããæªæ§ãããã©ã®æ²»çãå¹ããããããããã粟å¯ã«èŠæ¥µããããå¯èœæ§ããããç«ã®ä¹³è ºããã¯æ©æäžåŠæè¡ã§çºçãªã¹ã¯ãäžããããšãç¥ãããŠãããäºé²ã®èгç¹ãéèŠã ãæ¥é ããç«ã®ãè ¹ïŒä¹³è ºã®ã©ã€ã³ïŒã«æ²¿ã£ãŠãããããªããåªããè§Šã£ãŠãã§ãã¯ããç±³ç²å€§ã§ãæ°ã«ãªããã®ãããã°æ©ãã«ç£å»åž«ã«çžè«ããŠã»ããã
ð https://onlinelibrary.wiley.com/doi/10.1111/vco.70033
ðïž ç¬ç«è «çãã¥ãŒã¹ | all-i-need-are-dogs.blog

ã³ã¡ã³ããæ®ã